Introducing NEXA Ultra 50K: America's Largest Disposable E-Cigarette

Oct.21.2024
Introducing NEXA Ultra 50K: America's Largest Disposable E-Cigarette
NEXA introduces NEXA Ultra 50K, the largest disposable e-cigarette in the US market with 50,000 puffs.

Recently, 2Firsts noticed that the e-cigarette brand NEXA has launched a NEXA Ultra 50K disposable e-cigarette product, which is believed to be the e-cigarette product with the largest puff count in the American market to date, with the ability to be used up to 50,000 times.

 

Earlier, 2Firsts predicted that 50,000 units of disposable e-cigarette products would be launched in the US market in October this year, while conducting an inventory of new 40,000 units of disposable products. This prediction has been validated with the launch of NEXA Ultra 50K (for more details, refer to "Product Roundup: New 40,000-Puff Disposable E-Cigarettes in the US, Puff Count Race Intensifies).

 

Introducing NEXA Ultra 50K: America's Largest Disposable E-Cigarette
Super Luckee 45000 | Image source: Two Supreme

 

Following the news of luckeevape's Super Luckee 45000 disposable e-cigarette with 45,000 puffs(Super Luckee 45000: The Largest Disposable E-Cigarette in USA)The new product boasts 50,000 puffs, 20ml e-liquid capacity, and a 3D curved screen design, marking a new phase in the escalating puff count competition in the American e-cigarette market.

Introducing NEXA Ultra 50K: America's Largest Disposable E-Cigarette
Image source: vapesourcing website

 

Specifically, the main product features of the NEXA Ultra 50K include:

 

Nicotine concentration: 5% (50mg) 

Number of puffs: approximately 50,000 (normal mode) /30,000 (turbo mode) 

Battery capacity: 800mAh Rechargeable battery 

Charging method: USB Type-C charging 

E-liquid capacity: 20ml 

Screen features: 3D curved screen, with light effects and battery indicator 

Product flavors: 15 Product price: approximately $16.99

 

Introducing NEXA Ultra 50K: America's Largest Disposable E-Cigarette
Image source: Nexabar official website

 

In terms of appearance, the NEXA Ultra 50K adopts the popular 3D curved screen design, (The Rise of 3D Curved Screen E-cigarette Products)which allows for real-time monitoring of the product's battery power. It also features a transparent e-liquid reservoir, providing a clear display of the remaining e-liquid levels.

 

By comparing Super Luckee 45000 with 2Firsts, it was noted that both are high-capacity e-cigarette products. Super Luckee 45000 has a 50ml e-liquid capacity and approximately 45,000 puffs, while the NEXA Ultra 50K has a smaller 20ml e-liquid capacity but offers 50,000 puffs.

 

Introducing NEXA Ultra 50K: America's Largest Disposable E-Cigarette
Image source: Nexabar official website

 

According to a survey conducted by 2Firsts, it was found that the NEXA brand trademark belongs to LingYu Innovation Limited, which was established in December 2023 and is located in Hong Kong, China. The trademark "NEXA" was officially submitted for trademark application on June 28, 2024 and is currently still awaiting substantive examination.

 

Introducing NEXA Ultra 50K: America's Largest Disposable E-Cigarette
Source of the image: Tianyancha website

 

It is reported that the NEXA Ultra 50K has now launched on the official website of the Nexabar brand as well as on popular American e-cigarette distributor websites such as Vapesourcing and General Vape.

 


 

The product section of 2FIRSTS is dedicated to providing readers with the latest information on new products in the tobacco industry. We encourage readers to submit articles and share the latest products in the e-cigarette field with us.

 

If you have any unique insights or information, please feel free to contact us at carrie.cai@2firsts.com or scan the QR code below to get in touch.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | DOJO Launches BLAST10K Fresh in UK With 0+10ml E-Liquid Structure, Retaining 2+8ml Pod Compatibility
Product | DOJO Launches BLAST10K Fresh in UK With 0+10ml E-Liquid Structure, Retaining 2+8ml Pod Compatibility
DOJO launched the BLAST10K Fresh in the UK on September 4, 2026, introducing its INSTA-JUICED™ technology and a new 0+10ml structure that keeps e-liquid separated from the coil before activation. The device features a 1000mAh rechargeable battery, COREX BLAST dual-mesh technology and SSS leak-resistant technology, with a manufacturer-rated capacity of up to 10,000 puffs. It also retains compatibility with existing 2+8ml pods across the BLAST ecosystem. The launch introduces eight new flavors, including Matcha Strawberry, which DOJO describes as an industry first.
Market
Sep.04
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07
Australia’s Victoria Steps Up Illegal Tobacco Enforcement With Store Closures and Penalties of Up to A$2.5 Million
Australia’s Victoria Steps Up Illegal Tobacco Enforcement With Store Closures and Penalties of Up to A$2.5 Million
Australia’s state of Victoria has activated new powers allowing Tobacco Licensing Victoria and police to shut premises suspected of selling, supplying or possessing illicit tobacco for up to 90 days. Longer closures can be ordered by a magistrates’ court. Businesses subject to closure orders must generally cease all trading and will be placed on a public list. Breaching a closure order can carry penalties of up to A$2.5 million and 20 years in prison.
Sep.10
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Asia Manufacturing Corp. has invested ₱2.1 billion, or about $37 million, in its manufacturing site in Malvar, Batangas, Philippines, to expand tobacco-processing capabilities. About ₱1.9 billion is allocated to JTI's first Dry Ice Expanded Tobacco, or DIET, facility in Southeast Asia, while more than ₱177 million has been spent on expanding its Controlled Atmosphere treatment facility. The Batangas plant supplies the Philippine market and exports to 22 overseas markets, making it one of JTI's key manufacturing hubs in Asia.
Sep.24
Product | JT Expands Vote-Winning EVO Cacao Mint Crystal to Nationwide Retail in Japan, Adds 22-Stick Limited Pack at Same Price
Product | JT Expands Vote-Winning EVO Cacao Mint Crystal to Nationwide Retail in Japan, Adds 22-Stick Limited Pack at Same Price
Japan Tobacco (JT) will expand EVO Cacao Mint Crystal from limited channels to nationwide retail in Japan from October 6, 2026. The Ploom tobacco stick ranked first in the brand's first consumer voting campaign for new tobacco-stick SKUs held earlier this year. JT will also introduce a limited 22-stick pack at the same JPY 620 price as the standard 20-stick pack. The capsule-format product combines menthol with sweet, bittersweet cacao notes and adds a berry nuance when the capsule is crushed.
Sep.09
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22